News

Synta Pharmaceuticals, a developer and marketer of small molecule drugs, has treated the first patient in a Phase I/II clinical study of STA-9090, a novel heat shock protein

Oxygen Biotherapeutics, a developer of biotechnology products, has announced that the company will move ahead with a line of gels based on Oxycyte. The first and most basic

US-based UnitedHealthcare’s Golden Rule Insurance Company has introduced new coverage options to reportedly help make dental and vision care more affordable for consumers in 15 states and the

Perrigo Company, a healthcare supplier, has reported that its partner Cobrek Pharmaceuticals has filed an abbreviated new drug application for clindamycin phosphate foam 1%, a generic version of

Lux Biosciences, a biotechnology company, has completed enrollment in its Phase III Lucida clinical trial program for Lumitect. The Lucida clinical trial program is investigating the one-year use

Yousef Haj-Ahmad, president of Norgen Biotek, said: “We are excited about this OEM manufacturing and supply agreement for our best-in-class RNA isolation kits. Exiqon is well known for

Syneron said that its novel Laser-in-Handpiece concept, incorporated in its LiteTouch Erbium: YAG dental laser, represents a unique combination of superior power and high-speed cutting abilities, along with

Gardiner has served as medical director, global medical affairs & senior medical officer for Bristol-Myers Squibb (BMS) Medical Imaging and vice president, medical sciences for the medical imaging

According to the company, i3Cube replaces the need for multiple systems and applications to manage study activities with an integrated solution that centralizes study information into a single